Early Multimodal Therapy and Mechanical Ventilation
- Conditions
- Critical IllnessCritical Care
- Interventions
- Procedure: Late Multimodal TherapyProcedure: Early Multimodal Therapy
- Registration Number
- NCT06133504
- Lead Sponsor
- Fundación Santa Fe de Bogota
- Brief Summary
To assess the association between early multimodal therapy and the duration of invasive mechanical ventilation in the Intensive Care Unit at Fundación Santa Fe de Bogotá.
- Detailed Description
This study compares the impact of early multimodal therapy on mechanical ventilation duration in ICU patients. It is an open-label, randomized controlled clinical trial. Patients will be assigned to either early multimodal therapy or standard therapy (control) in a 1:1 ratio. Blinding is not possible due to the study design. The analysis will follow an intention-to-treat approach. The hypothesis is that early multimodal therapy reduces mechanical ventilation duration
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 74
The inclusion criteria are as follows:
Patients hospitalized in the adult intensive care unit of the Fundación Santa Fe de Bogotá.
Requirement of invasive mechanical ventilation through an endotracheal tube for a period exceeding 72 hours with an expected continuation of at least 24 hours.
Barthel Index equal to or greater than 70
Exclusion criteria:
- Patients requiring invasive mechanical ventilation through a tracheostomy tube or nasotracheal tube.
- Patients who have undergone any type of head and neck surgery.
- Cardiac arrest.
- Airway burn.
- Burns with an extent greater than 50% of the body surface area.
- Patients with chronic obstructive pulmonary disease.
- Patients referred from another institution.
- Demyelinating or neuromuscular junction diseases.
- Patients requiring neuromuscular blockade.
- Patients with a life expectancy of less than 180 days.
- Patients deemed by medical criteria not to benefit from multimodal treatment.
- Patients not entering the ICU for the first time.
- Patients participating in other clinical rehabilitation trials
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Late arm Late Multimodal Therapy While late multimodal therapy is characterized by the same type of maneuvers carried out by the same disciplinary team but initiated once indicated by the attending physician. Early arm Early Multimodal Therapy Early multimodal therapy is characterized by a comprehensive set of therapeutic interventions executed by the physiotherapy, speech therapy, respiratory therapy, and occupational therapy teams precisely at the moment of study inclusion. This tailored approach ensures that patients receive a coordinated and multidisciplinary therapeutic regimen right from the outset of their participation in the study
- Primary Outcome Measures
Name Time Method Time (days) from intubation to extubation. 28 days Days of mechanical ventilation duration
- Secondary Outcome Measures
Name Time Method Ventilator-free days until day 28 28 days 28 minus the days of mechanical ventilation
Delirium-free days until day 28 28 days 28 minus days with presence of delirium
Sedation days until day 28. 28 days Sedation days until day 28.
Hospitalization days 90 days Hospitalization days
Delirium days until day 28 28 days In order for a patient to be considered to have delirium according to the CAM-ICU, the first criterion (acute change in mental status) must be present, along with at least one of the other three criteria (inability to maintain sustained attention, disorganized thinking, or fluctuating levels of consciousness).
Swallowing difficulty at 72 hours. 28 days Presence of dysphagia at 72 hours after extubation
Extubation failure 28 days Inability to breathe spontaneously in the first 48 hours after removal of artificial airway, and the patient is unable to maintain a patent airway
Sedation-free days until day 28 28 days 28 days minus days of sedation
Mortality from any cause up to 90 days 90 days Mortality from any cause up to 90 days
Barthel Index at hospital discharge 90 days The Barthel Index is a scale used to measure the degree of functional independence in activities of daily living (ADLs) for an individual. The score is 0 if the patient deceases.
ICU length of stay 28 days ICU length of stay
Functional independence status measured by ADLs at ICU discharge 28 days Activities of Daily Living (ADLs), each variable scores one point: bathing, dressing, eating, grooming, transferring from bed to chair, and using the bathroom
Muscle strength measured using the Medical Research Council (MRC) scale 28 days Muscle strength assessment in critical care patients using the Medical Research Council (MRC) scale:
5: Normal - Full range of motion against total resistance 4+: Good (+) - Full range of motion against gravity and strong resistance 4: Good (-) - Full range of motion against gravity and minimal resistance 3+: Fair (+) - Full range of motion against gravity only 3: Fair (-) - Partial range of motion against gravity 2: Poor - Movement with gravity eliminated
1: Minimal - Visible muscle contraction without movement 0: Absent - Total paralysisFunctional independence status measured by ADLs at hospital discharge 90 days Activities of Daily Living (ADLs), each variable scores one point: bathing, dressing, eating, grooming, transferring from bed to chair, and using the bathroom
Time until the initiation of oral intake 28 days Time to initiate oral intake after extubation: 1) 12-24 hours, 2) \> 24 hours
Development of healthcare-associated pneumonia 28 days Pneumonia associated with invasive mechanical ventilation. Yes or no.
Grip strength 28 days Grip strength of the dominant hand within 24 hours post-extubation. Kilograms. Score is 0 if the patient deceases
Need for non-invasive mechanical ventilation 28 days Need for non-invasive mechanical ventilation: Yes or No
Cognitive function measured using the Montreal Cognitive Assessment (MOCA). 90 days The variable is the cognitive function, assessed using the Montreal Cognitive Assessment (MOCA). This tool measures various cognitive domains, providing insight into an individual's cognitive abilities and identifying potential cognitive impairment
Maximum mobility measured by JH-HLM (Johns Hopkins Highest Level of Mobility) scale 28 days Mobility assessment using the JH-HLM (Johns Hopkins Highest Level of Mobility) scale:
8: Walks more than 250 feet. 7: Walks more than 25 feet. 6: Walks more than 10 steps. 5: Stands for more than one minute. 4: Can move to the chair. 3: Can sit on the edge of the bed. 2: Can turn in bed.
1: Can only lie down. Score is 0 if the patient deceases.